VELMENI Secures FDA 510(k) for AI-Powered 3D CBCT Imaging
SUNNYVALE, Calif., July 23, 2026 VELMENI AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for VELMENI...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SUNNYVALE, Calif., July 23, 2026 VELMENI AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for VELMENI...
NEW YORK, July 21, 2026 Intelligent Bio Solutions Inc. announced the successful completion of precision testing, an important milestone...
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
AMSTERDAM, Netherlands, July 8, 2026 Philips announced the launch of Alturion, a next-generation AI-powered ultrasound system designed to improve...
RICHMOND HILL, N.Y., July 8, 2026 iHealthScreen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
SOPHIA ANTIPOLIS, France, July 2, 2026 Median Technologies has announced that its eyonis® LCS, an artificial intelligence (AI)-powered Software...
SALT LAKE CITY, Utah, July 1, 2026 Co-Diagnostics, Inc. has reached a significant regulatory milestone by completing the clinical...
HAYWARD, Calif., June 30, 2026 RefleXion Medical has announced the submission of a 510(k) premarket notification to the U.S....
LOS ANGELES, Calif., June 30, 2026 STARMED America has achieved a historic milestone in thyroid disease treatment after receiving...
VALENCIA, Calif., June 29, 2026 Bioness Medical, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
